chemotherapy did not reach statistical significance (HR, 0.43; 95% CI: 0.17–1.11; P=0.08).
← all excerpts
Real-world outcomes of first-line immunotherapy and subsequent systemic therapies in pleural mesothelioma: a multicenter study in China.
2
0.0800
0.0800
The sentences
chemotherapy ± targeted therapy (weighted HR, 0.47; 95% CI: 0.23–0.95) and showed a trend toward longer PFS (weighted HR, 0.64; 95% CI: 0.34–1.17).